Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Richette

Showing results (61-70 of 307) with videos related to

Pageof 31
Sort By:
Nature Reviews. Rheumatology|October 30, 2020
Emerging pharmaceutical therapies for osteoarthritisAugustin Latourte, Margreet Kloppenburg, Pascal Richette
Joint Bone Spine|September 3, 2003
Estrogens, cartilage, and osteoarthritisPascal Richette, Maïté Corvol, Thomas Bardin
Rheumatology (Oxford, England)|April 25, 2014
Prophylaxis for acute gout flares after initiation of urate-lowering therapyAugustin Latourte, Thomas Bardin, Pascal Richette
Rheumatology (Oxford, England)|April 29, 2009
An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition diseasePascal Richette, Thomas Bardin, Michael Doherty
JAMA Internal Medicine|January 26, 2026
Urate Lowering and Cardiovascular Risk-Extending the Benefits of a Treat-to-Target Strategy in GoutPascal Richette, Augustin Latourte, Hang-Korng Ea
Arthritis|June 5, 2014
Treatment of nongout joint deposition diseases: an updateTristan Pascart, Pascal Richette, René-Marc Flipo
Spine|August 2, 2008
Coccydynia related to calcium crystal depositionPascal Richette, Jean-Yves Maigne, Thomas Bardin
JAMA|August 21, 2024
Surrogate Markers and Clinical OutcomesPascal Richette, Nicola Dalbeth, Lisa K Stamp
Clinical and Experimental Rheumatology|October 21, 2011
An exploratory ultrasound study of early goutSébastien Ottaviani, Anne Allard, Thomas Bardin, et al.
The Journal of Rheumatology|August 5, 2010
Musculoskeletal complications of hereditary hemochromatosis: a case-control studyPascal Richette, Sébastien Ottaviani, Eric Vicaut, et al.
Pageof 31

Showing results (61-70 of 307) with videos related to

Sort By:
Pageof 31
Nature Reviews. Rheumatology|October 30, 2020
Emerging pharmaceutical therapies for osteoarthritisAugustin Latourte, Margreet Kloppenburg, Pascal Richette
Joint Bone Spine|September 3, 2003
Estrogens, cartilage, and osteoarthritisPascal Richette, Maïté Corvol, Thomas Bardin
Rheumatology (Oxford, England)|April 25, 2014
Prophylaxis for acute gout flares after initiation of urate-lowering therapyAugustin Latourte, Thomas Bardin, Pascal Richette
Rheumatology (Oxford, England)|April 29, 2009
An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition diseasePascal Richette, Thomas Bardin, Michael Doherty
JAMA Internal Medicine|January 26, 2026
Urate Lowering and Cardiovascular Risk-Extending the Benefits of a Treat-to-Target Strategy in GoutPascal Richette, Augustin Latourte, Hang-Korng Ea
Arthritis|June 5, 2014
Treatment of nongout joint deposition diseases: an updateTristan Pascart, Pascal Richette, René-Marc Flipo
Spine|August 2, 2008
Coccydynia related to calcium crystal depositionPascal Richette, Jean-Yves Maigne, Thomas Bardin
JAMA|August 21, 2024
Surrogate Markers and Clinical OutcomesPascal Richette, Nicola Dalbeth, Lisa K Stamp
Clinical and Experimental Rheumatology|October 21, 2011
An exploratory ultrasound study of early goutSébastien Ottaviani, Anne Allard, Thomas Bardin, et al.
The Journal of Rheumatology|August 5, 2010
Musculoskeletal complications of hereditary hemochromatosis: a case-control studyPascal Richette, Sébastien Ottaviani, Eric Vicaut, et al.
Pageof 31